We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Gabriel Bsteh PD, MD, PhD

Gabriel Bsteh PD, MD, PhD

Professor, Department of Neurology, Medical University of Vienna, Vienna, Austria

Gabriel Bsteh is a neurologist and clinical neuroscientist. He earned his MD and PhD at the Medical University of Innsbruck (Innsbruck, Austria) and currently holds a Junior Associate Professorship at the Medical University of Vienna, Department of Neurology (Vienna, Austria). His research is focused on personalized medicine in multiple sclerosis, particularly focussing on the developing biomarkers such as optical coherence tomography and olfactory function, as well as idiopathic intracranial hypertension.


Gabriel Bsteh has participated in meetings sponsored by and/or received speaker honoraria or travel funding from Biogen, Celgene/BMS, Lilly, Merck, Novartis, Roche, Sanofi-Genzyme and Teva and received honoraria for consulting from Biogen, Celgene/BMS, Novartis, Roche, Sanofi-Genzyme and Teva. He has received research grants from Celgene/BMS and Novartis.